Document:

Exhibit 10.29

 

JASPER THERAPEUTICS, INC.

CONSULTING AGREEMENT

 

Effective
Date: _______ December 16, 2019 ___

 

This Consulting Agreement
(the “Agreement”) is made as of the Effective Date set forth above by and between Jasper Therapeutics, Inc.,
a Delaware corporation (“Client”) and the consultant named on the signature page hereto (“Consultant”).

 

1. Engagement
of Services. Client may issue Project Assignments to Consultant in the form attached to this Agreement as Exhibit A (“Project
Assignment”). Subject to the terms of this Agreement, Consultant will render the services set forth in Project Assignment(s)
accepted by Consultant (the “Services”) by the completion dates set forth therein. Except as otherwise provided
in the applicable Project Assignment, Consultant will have exclusive control over the manner and means of performing the Services, including
the choice of place and time. Consultant will provide, at Consultant’s own expense, a place of work and all equipment, tools and
other materials necessary to complete the Services; however, to the extent necessary to facilitate performance of the Services, Client
may, in its discretion, make its equipment or facilities available to Consultant at Consultant’s request. While on the Client’s
premises, Consultant agrees to comply with Client’s then-current access rules and procedures, including those related to safety,
security and confidentiality. Consultant agrees and acknowledges that Consultant has no expectation of privacy with respect to Client’s
telecommunications, networking or information processing systems (including stored computer files, email messages and voice messages)
and that Consultant’s activities, including the sending or receiving of any files or messages, on or using those systems may be
monitored, and the contents of such files and messages may be reviewed and disclosed, at any time, without notice.

 

2. Compensation.
Client will pay Consultant the fee set forth in each Project Assignment for Services rendered pursuant to this Agreement as Consultant’s
sole compensation for such Services. Consultant will be reimbursed only for expenses that are expressly provided for in a Project Assignment
or that have been approved in advance in writing by Client, provided Consultant has furnished such documentation for authorized expenses
as Client may reasonably request. Payment of Consultant’s fees and expenses will be in accordance with terms and conditions set
forth in the applicable Project Assignment. Upon termination of this Agreement for any reason, Consultant will be paid fees on the basis
stated in the Project Assignment(s) for work which has been completed. Unless otherwise provided in a Project Assignment, payment to Consultant
of undisputed fees will be due 30 days following Client’s receipt of an invoice that contains accurate records of the work performed
sufficient to document the invoiced fees.

 

3. Ownership
of Work Product. Consultant agrees that any and all Work Product (as defined below) will be the sole and exclusive property of Client.
Consultant hereby irrevocably assigns to Client all right, title and interest worldwide in and to any deliverables specified in a Project
Assignment (“Deliverables”), and to any ideas, concepts, processes, discoveries, developments, formulae, information,
materials, improvements, designs, artwork, content, software programs, other copyrightable works, and any other work product created,
conceived or developed by Consultant (whether alone or jointly with others) for Client during or before the term of this Agreement, including
all copyrights, patents, trademarks, trade secrets, and other intellectual property rights therein (the “Work Product”).
Consultant retains no rights to use the Work Product and agrees not to challenge the validity of Client’s ownership of the Work
Product. Consultant agrees to execute, at Client’s request and expense, all documents and other instruments necessary or desirable
to confirm such assignment, including without limitation, the copyright assignment set forth as Exhibit B (“Assignment
of Copyright”) and the patent assignment set forth as Exhibit C (“Assignment of Patent Application”).
Consultant hereby irrevocably appoints Client as Consultant’s attorney-in-fact for the purpose of executing such documents on Consultant’s
behalf, which appointment is coupled with an interest. Consultant will deliver any Deliverables in accordance with the applicable Project
Assignment and disclose promptly in writing to Client all other Work Product.

 

     

     

    

 

4. Other
Rights. If Consultant has any rights, including without limitation “artist’s rights” or “moral rights,”
in the Work Product that cannot be assigned, Consultant hereby unconditionally and irrevocably grants to Client an exclusive (even as
to Consultant), worldwide, fully paid and royalty-free, irrevocable, perpetual license, with rights to sublicense through multiple tiers
of sublicensees, to use, reproduce, distribute, create derivative works of, publicly perform and publicly display the Work Product in
any medium or format, whether now known or later developed. In the event that Consultant has any rights in the Work Product that cannot
be assigned or licensed, Consultant unconditionally and irrevocably waives the enforcement of such rights, and all claims and causes of
action of any kind against Client or Client’s customers.

 

5. License
to Preexisting IP. Consultant agrees not to use or incorporate into Work Product any intellectual property developed by any third
party or by Consultant other than in the course of performing services for Client (“Preexisting IP”). In the
event Consultant uses or incorporates Preexisting IP into Work Product, Consultant shall immediately so notify the Company in writing,
and will provide commercially reasonable efforts to assist the Company in procuring a license to such Preexisting IP. However, in no event
will Consultant incorporate into the Work Product any software code licensed under the GNU GPL or LGPL or any similar “open source”
license. Consultant represents and warrants that Consultant has an unqualified right to license to Client all Preexisting IP as provided
in this section.

 

6. Representations
and Warranties. Consultant represents and warrants that: (a) the Services will be performed in a professional manner and in accordance
with the industry standards and the Work Product will comply with the requirements set forth in the applicable Project Assignment, (b)
Work Product will be an original work of Consultant, (c) Consultant has the right and unrestricted ability to assign the ownership of
Work Product to Client as set forth in Section 3 (including without limitation the right to assign the ownership of any Work Product created
by Consultant’s employees or contractors), (d) neither the Work Product nor any element thereof will infringe upon or misappropriate
any copyright, patent, trademark, trade secret, right of publicity or privacy, or any other proprietary right of any person, whether contractual,
statutory or common law, and (e) Consultant will comply with all applicable federal, state, local and foreign laws governing self-employed
individuals, including laws requiring the payment of taxes, such as income and employment taxes, and social security, disability, and
other contributions. Consultant agrees to indemnify and hold Client harmless from any and all damages, costs, claims, expenses or other
liability (including reasonable attorneys’ fees) arising from or relating to the breach or alleged breach by Consultant of the representations
and warranties set forth in this Section 6.

 

    2.

     

    

 

7. Independent
Contractor Relationship. Consultant’s relationship with Client is that of an independent contractor, and nothing in this Agreement
is intended to, or should be construed to, create a partnership, agency, joint venture or employment relationship between Client and any
of Consultant’s employees or agents. Consultant is not authorized to make any representation, contract or commitment on behalf of
Client. Consultant (if Consultant is an individual) and Consultant’s employees will not be entitled to any of the benefits that
Client may make available to its employees, including, but not limited to, group health or life insurance, profit-sharing or retirement
benefits. Because Consultant is an independent contractor, Client will not withhold or make payments for social security, make unemployment
insurance or disability insurance contributions, or obtain workers’ compensation insurance on behalf of Consultant. Consultant is
solely responsible for, and will file, on a timely basis, all tax returns and payments required to be filed with, or made to, any federal,
state or local tax authority with respect to the performance of Services and receipt of fees under this Agreement. Consultant is solely
responsible for, and must maintain adequate records of, expenses incurred in the course of performing Services under this Agreement. No
part of Consultant’s compensation will be subject to withholding by Client for the payment of any social security, federal, state
or any other employee payroll taxes. Client will regularly report amounts paid to Consultant by filing Form 1099-MISC with the Internal
Revenue Service as required by law. If, notwithstanding the foregoing, Consultant is reclassified as an employee of Client, or any affiliate
of Client, by the U.S. Internal Revenue Service, the U.S. Department of Labor, or any other federal or state or foreign agency as the
result of any administrative or judicial proceeding, Consultant agrees that Consultant will not, as the result of such reclassification,
be entitled to or eligible for, on either a prospective or retrospective basis, any employee benefits under any plans or programs established
or maintained by Client.

 

8. Stanford
Affiliation.

 

8.1 Client
acknowledges that Consultant is a full-time member of the Blood and Marrow Transplantation faculty, the Immunology Program and the Institute
of Stem Cell Biology and Regenerative Medicine at Stanford University (“Stanford”) and, as such, Consultant’s
primary duty is to Stanford. Consultant is subject to Stanford’s policies, including Sections 4.3 (Consulting and Other Outside
Professional Activities by Members of the Academic Council and Medical Center Line Facility) and 9.1 (Inventions, Patents and Licensing)
of the Stanford Research Policy Handbook (“RPH”) policies (“Stanford’s Policies”),
a copy of which has been provided to Client by Consultant and is attached hereto as Exhibit D. Consultant has no additional obligations
to Stanford by reason of any agreement between Consultant and Stanford or any agreements between Stanford and external organizations for
research and other activities performed by Consultant in fulfilling her duties to Stanford. Client further acknowledges and agrees that
nothing in this Agreement shall affect Consultant’s obligations to, or research on behalf of, Stanford.

 

    3.

     

    

 

8.2 Consultant
represents and warrants that (a) Consultant has a good faith belief that Stanford will not oppose the arrangements set forth in this Agreement;
(b) Consultant shall comply with Stanford’s Policies; (c) Consultant shall not exceed Stanford’s maximum time limit of 13
days per academic quarter for Services under this Agreement; and (d) Consultant shall use best efforts to avoid any conflict between Consultant’s
obligations under this Agreement and Consultant’s obligations under Stanford’s Policies.

 

8.3 In
performing the Services hereunder, Consultant shall not use any facilities, personnel, equipment or other resources of Stanford except
for “purely incidental uses.” For purposes of this Agreement, an “incidental use” of Stanford resources shall
be defined, as set forth in Section 9.1.2.D of the RPH, as the occasional and infrequent use of the following: routinely available office-type
equipment, including desktop computers and commercially available software, and reference materials or other resources collected on the
Stanford campus, and which are generally available in non-Stanford locations. “Incidental use” of Stanford resources shall
exclude all other uses of such facilities, personnel, equipment or other resources of Stanford, including but not limited to the use of
specialized, research-related facilities, equipment or supplies, provided by Stanford for academic purposes, and significant use of “on-the-job”
time.

 

8.4 Nothing
in this Agreement shall require Consultant to, and in performing the Services Consultant shall not: (a) provide preferential access to
research results, materials or products generated from Consultant’s teaching or research activities at Stanford; (b) grant unauthorized
access to confidential information acquired through Consultant’s conduct of Stanford’s business or research activities; or
(c) participate in dedicated marketing and training programs designed solely or predominantly for Client’s sales or marketing purposes.

 

8.5 Consultant
has provided to Client the Stanford University Requirements for Faculty Consulting Activities and Agreements, a copy of which is attached
to this Agreement as Exhibit E (Stanford University Requirements for Faculty Consulting Activities and Agreements). If Consultant
is required by Stanford, pursuant to applicable guidelines or policies, to make any disclosure or take any action that conflicts with
(or may conflict with) the Services or that is contrary to the terms of this Agreement, Consultant shall promptly, but in any case prior
to making such disclosure or taking such action, notify Client of such obligation, specifying the nature of such disclosure or action
and identifying the applicable guideline or policy under which disclosure or action is required.

 

9. Confidential
Information. Consultant agrees that during the term of this Agreement and thereafter it will not use or permit the use of Client’s
Confidential Information in any manner or for any purpose not expressly set forth in this Agreement, will hold such Confidential Information
in confidence and protect it from unauthorized use and disclosure, and will not disclose such Confidential Information to any third parties
except as set forth in Section 10 below. “Confidential Information” as used in this Agreement means all information
disclosed by Client to Consultant, whether during or before the term of this Agreement, that is not generally known in the Client’s
trade or industry and will include, without limitation: (a) concepts and ideas relating to the development and distribution of content
in any medium or to the current, future and proposed products or services of Client or its subsidiaries or affiliates; (b) trade secrets,
drawings, inventions, know-how, software programs, and software source documents; (c) information regarding plans for research, development,
new service offerings or products, marketing and selling, business plans, business forecasts, budgets and unpublished financial statements,
licenses and distribution arrangements, prices and costs, suppliers and customers; (d) existence of any business discussions, negotiations
or agreements between the parties; and (e) any information regarding the skills and compensation of employees, contractors or other agents
of Client or its subsidiaries or affiliates. Confidential Information also includes proprietary or confidential information of any third
party who may disclose such information to Client or Consultant in the course of Client’s business. Confidential Information does
not include information that (x) is or becomes a part of the public domain through no act or omission of Consultant, (y) is disclosed
to Consultant by a third party without restrictions on disclosure, or (z) was in Consultant’s lawful possession prior to the disclosure
and was not obtained by Consultant either directly or indirectly from Client. In addition, this section will not be construed to prohibit
disclosure of Confidential Information to the extent that such disclosure is required by law or valid order of a court or other governmental
authority; provided, however, that Consultant will first have given notice to Client and will have made a reasonable effort
to obtain a protective order requiring that the Confidential Information so disclosed be used only for the purposes for which the order
was issued. All Confidential Information furnished to Consultant by Client is the sole and exclusive property of Client or its suppliers
or customers. Upon request by Client, Consultant agrees to promptly deliver to Client the original and any copies of the Confidential
Information. Notwithstanding the foregoing nondisclosure obligations, pursuant to 18 U.S.C. Section 1833(b), Consultant will not be held
criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made: (1) in confidence
to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting
or investigating a suspected violation of law; or (2) in a complaint or other document filed in a lawsuit or other proceeding, if such
filing is made under seal.

 

    4.

     

    

 

10. Consultant’s
Employees, Consultants and Agents. Consultant will ensure that each of its employees, consultants and agents who will have access
to any Confidential Information or perform any Services has entered into a binding written agreement that is expressly for the benefit
of Client and protects Client’s rights and interests to at least the same degree as Section 9. Client reserves the right to refuse
or limit Consultant’s use of any employee, consultant or agent or to require Consultant to remove any employee, consultant or agent
already engaged in the performance of the Services. Client’s exercise of such right will in no way limit Consultant’s obligations
under this Agreement.

 

11. No
Conflict of Interest. During the term of this Agreement, Consultant will not accept work, enter into a contract, or accept an obligation
from any third party, inconsistent or incompatible with Consultant’s obligations, or the scope of Services rendered for Client,
under this Agreement. Consultant warrants that there is no other contract or duty on its part inconsistent with this Agreement. Consultant
agrees to indemnify Client from any and all loss or liability incurred by reason of the alleged breach by Consultant of any services agreement
with any third party.

 

12. Term
and Termination.

 

12.1 Term.
The initial term of this Agreement is for 1 year from the Effective Date set forth above, unless earlier terminated as provided in this
Agreement. Thereafter, this Agreement will automatically renew on its anniversary date, for one year terms, unless Client provides 15
days’ written notice prior to any such anniversary date that the Agreement will not renew.

 

12.2 Termination
Without Cause. Client may terminate this Agreement with or without cause, at any time upon 15 days’ prior written notice to
Consultant. Consultant may terminate this Agreement without cause, at any time when no Project Assignment is in effect upon 30 days’
prior written notice to Client.

 

    5.

     

    

 

12.3 Termination
for Cause. Either party may terminate this Agreement immediately in the event the other party has materially breached the Agreement
and failed to cure such breach within 15 days after notice by the non-breaching party is given.

 

12.4 Survival.
The rights and obligations contained in Sections 3 (“Ownership of Work Product”), 4 (“Other Rights”),
5 (“License to Preexisting IP”), 6 (“Representations and Warranties”), 9 (“Confidential
Information”) and 13 (“Noninterference with Business”) will survive any termination or expiration
of this Agreement.

 

13. Noninterference
with Business. Consultant agrees that during the Term of this Agreement, Consultant will not, without Client’s express written
consent, either directly or indirectly engage in any employment or business activity that is competitive with, or would otherwise conflict
with the Services rendered to, or that would otherwise interfere with the business of, the Client. Consultant agrees that during the Term
of this Agreement, and for one year thereafter, Consultant will not either directly or indirectly, solicit or attempt to solicit any employee,
independent contractor, or consultant of Client to terminate his, her or its relationship with Client in order to become an employee,
consultant, or independent contractor to or for any other person or entity.

 

14. Successors
and Assigns. Consultant may not subcontract or otherwise delegate or assign this Agreement or any of its obligations under this Agreement
without Client’s prior written consent. Any attempted assignment in violation of the foregoing will be null and void. Subject to
the foregoing, this Agreement will be for the benefit of Client’s successors and assigns, and will be binding on Consultant’s
assignees.

 

15. Notices.
Any notice required or permitted by this Agreement will be in writing and will be delivered as follows with notice deemed given as indicated:
(a) by personal delivery when delivered personally; (b) by overnight courier upon written verification of receipt; (c) by telecopy or
facsimile transmission upon acknowledgment of receipt of electronic transmission; or (d) by certified or registered mail, return receipt
requested, upon verification of receipt. Notice will be sent to the addresses set forth below or such other address as either party may
specify in writing.

 

16. Governing
Law. This Agreement will be governed in all respects by the laws of the United States of America and by the laws of the State of Delaware,
without giving effect to any conflicts of laws principles that require the application of the law of a different jurisdiction.

 

17. Severability.
Should any provisions of this Agreement be held by a court of law to be illegal, invalid or unenforceable, the legality, validity and
enforceability of the remaining provisions of this Agreement will not be affected or impaired thereby.

 

    6.

     

    

 

18. Waiver.
The waiver by Client of a breach of any provision of this Agreement by Consultant will not operate or be construed as a waiver of any
other or subsequent breach by Consultant.

 

19. Injunctive
Relief for Breach. Consultant’s obligations under this Agreement are of a unique character that gives them particular value;
breach of any of such obligations will result in irreparable and continuing damage to Client for which there will be no adequate remedy
at law; and, in the event of such breach, Client will be entitled to injunctive relief and/or a decree for specific performance, and such
other and further relief as may be proper (including monetary damages if appropriate).

 

20. Entire
Agreement. This Agreement constitutes the entire agreement between the parties relating to this subject matter and supersedes all
prior or contemporaneous oral or written agreements concerning such subject matter. The terms of this Agreement will govern all services
undertaken by Consultant for Client; provided, however, that in the event of any conflict between the terms of this Agreement
and any Project Assignment, the terms of the applicable Project Assignment will control. This Agreement may only be changed or amended
by mutual agreement of authorized representatives of the parties in writing. This Agreement may be executed in two or more counterparts,
each of which will be deemed an original, but all of which together will constitute one and the same instrument. Counterparts may be delivered
via facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic
Transactions Act or other applicable law) or other transmission method and any counterpart so delivered will be deemed to have been duly
and validly delivered and be valid and effective for all purposes.

 

[Signature
Pages Follow]

 

    7.

     

    

 

The parties have executed
this Agreement as of the Effective Date.

 

	 	CLIENT:
	 	 	 
	 	Jasper Therapeutics, Inc.
	 	 	 
	 	By:	/s/ Susan Prohaska
	 	Name: 	Susan Prohaska
	 	Title:	Chief Executive Officer
	 	 	 
	 	Email: 	[...***...]

 

	 	Address:	725 Mariposa Avenue
 Suite 207
 Mountain View, California 94041

 

	 	CONSULTANT:
	 	 
	 	Judith Shizuru
	 	Name of Consultant (Please Print)
	 	 
	 	/s/ Judith Shizuru
	 	Signature
	 	 
	 	 
	 	Title (if applicable)
	 	 
	 	[...***...]
	 	Email

 

	 	Address:	[...***...]
	 	 	[...***...]
	 	 	 

 

    8.

     

    

 

EXHIBIT A

 

Project Assignment #1 Under Consulting Agreement

 

Effective Date: _________ December 16, 2019
_________

 

Project:

 

Consultant will render such services as Client
may from time to time request, including, without limiting the generality of the foregoing:

 

		·	13 days per academic quarter of clinical and scientific guidance to the Company related to the Company’s
clinical and scientific development of the antibody known internally by Company as JSP 191 or AMG 191 and additional pre-clinical and
clinical development of pipeline programs as they arise.

 

		·	Service as Chair of the Jasper Therapeutics Scientific Advisory Board (SAB) responsible for 4 SAB meetings
per year.

 

 

 

Schedule Of Work: Work is to be performed
commencing December 16, 2019 and continue on an on-going basis.

 

Fees And Reimbursement:

 

Cash Fee: $20,833.00 per month

 

    A-1

     

    

 

 

The parties have executed
this Project Assignment as of the date first written above.

 

 

	 	CLIENT:
	 	 	 
	 	JASPER THERAPEUTICS, INC.
	 	 	 
	 	By:	/s/ Susan Prohaska
	 	Name: 	Susan Prohaska
	 	Title:	Chief Executive Officer

 

	 	CONSULTANT:
	 	 
	 	Judith Shizuru
	 	Name of Consultant (Please Print)
	 	 
	 	/s/ Judith Shizuru
	 	Signature
	 	 
	 	 
	 	Title (if applicable)

 

 

    A-2

     

    

 

EXHIBIT B

 

ASSIGNMENT OF COPYRIGHT

 

For good and valuable consideration that has been
received, the undersigned sells, assigns and transfers to Client and its successors and assigns, the copyright in and to the following
work, which was created by the following indicated author(s):

 

Title: _________________________________________________________________

 

Author(s): _____________________________________________________________

 

Copyright Office Identification No. (if any):
__________________________________

 

and all of the right, title and interest of the
undersigned, vested and contingent, therein and thereto.

 

Executed as of ____________________________.

 

	 	CONSULTANT:
	 	 
	 	 
	 	Name of Consultant (Please Print)
	 	 
	 	 
	 	Signature
	 	 
	 	 
	 	Title (if applicable)

 

	STATE OF CALIFORNIA	)
	 	) ss.
	COUNTY OF	)

 

On ___________, 201__ before me, ________________________
Notary Public, personally appeared __________, personally known to me (or proved to me on the basis of satisfactory evidence) to be the
person whose name is subscribed to the within instrument and acknowledged to me that he executed the same in his authorized capacity,
and that by his signature on the instrument the person, or the entity upon behalf of which the person acted, executed the instrument.
Witness my hand and official seal.

 

Signature of Notary Public

 

My commission expires on: _______________

 

    B-1

     

    

 

EXHIBIT C

 

ASSIGNMENT OF PATENT APPLICATIONS

 

	Client	 	Consultant
	 	 	 
	Name:	 Jasper Therapeutics, Inc.	 	Name:	  
	Entity Type: 	Corporation	 	Entity Type:	  
	Address:	725 Mariposa Avenue Suite 207 Mountain View, California 94041	 	Address:

 

Whereas the individual or entity identified as
Consultant above (“Consultant”) owns all right, title, and interest in and to the U.S. patent applications listed in
Schedule C-1 (the “Patent Applications”); and

 

Whereas Jasper Therapeutics, Inc. (“Client”)
desires to acquire Consultant’s entire right, title, and interest in and to the Patent Applications, and in and to the inventions
disclosed in the Patent Applications, and to the Future Patents (as hereinafter defined);

 

Now therefore, for and in consideration of one
dollar ($1.00) payable upon demand and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
Consultant does hereby sell, assign, and transfer to Client and its successors, assigns, and legal representatives, all right, title,
and interest in and to the Patent Applications, and to all future patents which may be granted therefor throughout the world, and all
divisions, reissues, reexaminations, substitutions, continuations, continuations-in-part, utility conversions, and extensions thereof
(collectively, “Future Patents”), together with all claims, causes of action, and damages for past infringement, if
any, of said Patent Applications and Future Patents; and Consultant hereby authorizes and requests the United States Patent and Trademark
Office and other patent offices throughout the world to issue all Future Patents resulting therefrom (insofar as Consultant’s interest
is concerned) to Client.

 

Consultant also hereby sells, assigns, and transfers
to Client and its successors, assigns, and legal representatives all right, title, and interest to the inventions disclosed in the Patent
Applications and Future Patents throughout the world, including the right to file applications for and obtain patents, utility models,
and industrial models, and designs for such inventions in Client’s own name throughout the world including all rights of priority,
all rights to publish cautionary notices reserving ownership of such inventions, and all rights to register such inventions in appropriate
registries; and Consultant further agrees to execute any and all powers of attorney, applications, assignments, declarations, affidavits,
and any other papers in connection therewith reasonably necessary to perfect such right, title, and interest in Client and its successors,
assigns, and legal representatives.

 

[Remainder of page intentionally left blank]

 

    C-1

     

    

 

 

Consultant has caused this
instrument to be executed effective as of _____________.

 

	 	CONSULTANT:
	 	 
	 	   
	 	Name of Consultant (Please Print)
	 	 
	 	 
	 	Signature
	 	 
	 	 
	 	Title (if applicable)

 

 

C-2Exhibit
10.1

 

THIS
PROMISSORY NOTE (“NOTE”) HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”). THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT ONLY AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF REGISTRATION
OF THE RESALE THEREOF UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY IN FORM, SCOPE AND SUBSTANCE TO THE COMPANY
THAT SUCH REGISTRATION IS NOT REQUIRED.

 

PROMISSORY
NOTE

 

	Principal
    Amount: $300,000	 	Dated
    as of April 19, 2021

 

Oxbridge
Acquisition Corp., a Cayman Islands exempted company (the “Maker”), promises to pay to the order OAC Sponsor Ltd.
or its registered assigns or successors in interest (the “Payee”), or order, the principal sum of Three Hundred Thousand
Dollars ($300,000) or such lesser amount as shall have been advanced by Payee to Maker and shall remain unpaid under this Note on the
Maturity Date (as defined below) in lawful money of the United States of America, on the terms and conditions described below. All payments
on this Note shall be made by check or wire transfer of immediately available funds or as otherwise determined by the Maker to such account
as the Payee may from time to time designate by written notice in accordance with the provisions of this Note.

 

1.
Principal. The entire unpaid principal balance of Note shall be payable on the earlier of: (i) September 30, 2021, or (ii) the date
on which Maker consummates an initial public offering of its securities (such earlier date, the “Maturity Date”).
The principal balance may be prepaid at any time. Under no circumstances shall any individual, including but not limited to any officer,
director, employee or shareholder of the Maker, be obligated personally for any obligations or liabilities of the Maker hereunder.

 

2.
Drawdown Requests. Maker and Payee agree that Maker may request, from time to time, up to Three Hundred Thousand Dollars ($300,000)
in draw downs under this Note to be used for costs and expenses related to Maker’s formation and the proposed initial public offering
of its securities (the “IPO”). Principal of this Note may be drawn down from time to time prior to the Maturity Date
upon written request from Maker to Payee (each, a “Drawdown Request”). Each Drawdown Request must state the amount
to be drawn down, and must not be an amount less than Ten Thousand Dollars ($10,000). Payee shall fund each Drawdown Request no later
than three (3) business days after receipt of a Drawdown Request; provided, however, that the maximum amount of drawdowns outstanding
under this Note at any time may not exceed Three Hundred Thousand Dollars ($300,000). No fees, payments or other amounts shall be due
to Payee in connection with, or as a result of, any Drawdown Request by Maker.

 

3.
Interest. No interest shall accrue on the unpaid principal balance of this Note.

 

4.
Application of Payments. All payments shall be applied first to payment in full of any costs incurred in the collection of any sum
due under this Note, including (without limitation) reasonable attorney’s fees, then to the payment in full of any late charges
and finally to the reduction of the unpaid principal balance of this Note.

 

5.
Events of Default. The following shall constitute an event of default (“Event of Default”):

 

	 	a)	Failure
    to Make Required Payments. Failure by Maker to pay the principal amount due pursuant to this Note within five (5) business days
    of the date specified above.
	 	 	 
	 	b)	Voluntary
Bankruptcy, Etc. The commencement by Maker of a voluntary case under any applicable bankruptcy, insolvency, reorganization, rehabilitation
or other similar law, or the consent by it to the appointment of or taking possession by a receiver, liquidator, assignee, trustee, custodian,
sequestrator (or other similar official) of Maker or for any substantial part of its property, or the making by it of any assignment
for the benefit of creditors, or the failure of Maker generally to pay its debts as such debts become due, or the taking of corporate
action by Maker in furtherance of any of the foregoing.

 

    	 

     

    

 

	 	c)	Involuntary
    Bankruptcy, Etc. The entry of a decree or order for relief by a court having jurisdiction in the premises in respect of Maker
    in an involuntary case under any applicable bankruptcy, insolvency or other similar law, or appointing a receiver, liquidator, assignee,
    custodian, trustee, sequestrator (or similar official) of Maker or for any substantial part of its property, or ordering the winding-up
    or liquidation of its affairs, and the continuance of any such decree or order unstayed and in effect for a period of 60 consecutive
    days.

 

6.
Remedies.

 

a)
Declaration of Default. Upon the occurrence of an Event of Default specified in Section 5(a) hereof, Payee may, by written notice
to Maker, declare this Note to be due immediately and payable, whereupon the unpaid principal amount of this Note, and all other amounts
payable thereunder, shall become immediately due and payable without presentment, demand, protest or other notice of any kind, all of
which are hereby expressly waived, anything contained herein or in the documents evidencing the same to the contrary notwithstanding.

 

b)
Automatic Default. Upon the occurrence of an Event of Default specified in Sections 5(b) or 5(c), the unpaid principal balance
of this Note, and all other sums payable with regard to this Note, shall automatically and immediately become due and payable, in all
cases without any action on the part of Payee.

 

7.
Waivers. Maker and all endorsers and guarantors of, and sureties for, this Note waive presentment for payment, demand, notice of
dishonor, protest, and notice of protest with regard to the Note, all errors, defects and imperfections in any proceedings instituted
by Payee under the terms of this Note, and all benefits that might accrue to Maker by virtue of any present or future laws exempting
any property, real or personal, or any part of the proceeds arising from any sale of any such property, from attachment, levy or sale
under execution, or providing for any stay of execution, exemption from civil process, or extension of time for payment; and Maker agrees
that any real estate that may be levied upon pursuant to a judgment obtained by virtue hereof, on any writ of execution issued hereon,
may be sold upon any such writ in whole or in part in any order desired by Payee.

 

8.
Unconditional Liability. Maker hereby waives all notices in connection with the delivery, acceptance, performance, default, or enforcement
of the payment of this Note, and agrees that its liability shall be unconditional, without regard to the liability of any other party,
and shall not be affected in any manner by any indulgence, extension of time, renewal, waiver or modification granted or consented to
by Payee, and consents to any and all extensions of time, renewals, waivers, or modifications that may be granted by Payee with respect
to the payment or other provisions of this Note, and agrees that additional makers, endorsers, guarantors, or sureties may become parties
hereto without notice to Maker or affecting Maker’s liability hereunder.

 

9.
Notices. All notices, statements or other documents which are required or contemplated by this Agreement shall be: (i) in writing
and delivered personally or sent by first class registered or certified mail, overnight courier service or facsimile or electronic transmission
to the address designated in writing, (ii) by facsimile to the number most recently provided to such party or such other address or fax
number as may be designated in writing by such party and (iii) by electronic mail, to the electronic mail address most recently provided
to such party or such other electronic mail address as may be designated in writing by such party. Any notice or other communication
so transmitted shall be deemed to have been given on the day of delivery, if delivered personally, on the business day following receipt
of written confirmation, if sent by facsimile or electronic transmission, one (1) business day after delivery to an overnight courier
service or five (5) days after mailing if sent by mail.

 

10.
Construction. THIS NOTE SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICT
OF LAW PROVISIONS THEREOF.

 

11.
Severability. Any provision contained in this Note which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction,
be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such
prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

 

    	 

     

    

 

12.
Trust Waiver. Notwithstanding anything herein to the contrary, the Payee hereby waives any and all right, title, interest or claim
of any kind (“Claim”) in or to any distribution of or from the trust account to be established in which the proceeds
of the IPO conducted by the Maker (including the deferred underwriters discounts and commissions) and the proceeds of the sale of the
warrants issued in a private placement to occur prior to the consummation of the IPO are to be deposited, as described in greater detail
in the registration statement and prospectus to be filed with the Securities and Exchange Commission in connection with the IPO, and
hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim against the trust account for any reason whatsoever.

 

13.
Amendment; Waiver. Any amendment hereto or waiver of any provision hereof may be made with, and only with, the written consent of
the Maker and the Payee.

 

14.
Assignment. No assignment or transfer of this Note or any rights or obligations hereunder may be made by any party hereto (by operation
of law or otherwise) without the prior written consent of the other party hereto and any attempted assignment without the required consent
shall be void.

 

IN
WITNESS WHEREOF, Maker, intending to be legally bound hereby, has caused this Note to be duly executed by the undersigned as of the
day and year first above written.

 

	 	Oxbridge
    Acquisition Corp.
	 	 
	 	By:	/s/
    Jay Madhu
	 	Name:	Jay
Madhu
	 	Title:	Chief
    Executive Officer and Director

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}]]